JN Miami Valley Hospital
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 96: 465-470, 2006. First published May 10, 2006; doi:10.1152/jn.00216.2006
0022-3077/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
96/1/465    most recent
00216.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tedford, H. W.
Right arrow Articles by Zamponi, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tedford, H. W.
Right arrow Articles by Zamponi, G. W.

REPORT

Scanning Mutagenesis Reveals a Role for Serine 189 of the Heterotrimeric G-Protein Beta 1 Subunit in the Inhibition of N-Type Calcium Channels

H. William Tedford, Alexandra E. Kisilevsky, Jean B. Peloquin and Gerald W. Zamponi

Department of Physiology and Biophysics, Faculty of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada

Submitted 1 March 2006; accepted in final form 3 April 2006


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Direct interactions between the presynaptic N-type calcium channel and the beta subunit of the heterotrimeric G-protein complex cause voltage-dependent inhibition of N-type channel activity, crucially influencing neurotransmitter release and contributing to analgesia caused by opioid drugs. Previous work using chimeras of the G-protein beta subtypes Gbeta1 and Gbeta5 identified two 20–amino acid stretches of structurally contiguous residues on the Gbeta1 subunit as critical for inhibition of the N-type channel. To identify key modulation determinants within these two structural regions, we performed scanning mutagenesis in which individual residues of the Gbeta1 subunit were replaced by corresponding Gbeta5 residues. Our results show that Gbeta1 residue Ser189 is critical for N-type calcium channel modulation, whereas none of the other Gbeta1 mutations caused statistically significant effects on the ability of Gbeta1 to inhibit N-type channels. Structural modeling shows residue 189 is surface exposed, consistent with the idea that it may form a direct contact with the N-type calcium channel {alpha}1 subunit during binding interactions.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
N-type and P/Q-type calcium channels are inhibited in response to activation of G-protein–coupled receptors (GPCRs), with crucial consequences for synaptic activity, neurotransmitter release, and nociception (Dunlap et al. 1995Go; Wheeler et al. 1994Go; Zamponi 2001Go). It is now known that heterodimers of the G-protein beta and {gamma} subunits interact directly with N-type and P/Q-type channels, causing steady-state inhibition of the channels and increasing their time constant of activation. Both aspects of this modulation depend on membrane potential and can be relieved by either application of strong depolarizations or trains of action potentials (Dolphin 2003Go; Page et al. 1997Go). The extent of inhibition is dependent on both calcium channel subtype and on the G-protein beta subunit isoform (Arnot et al. 2000Go; Garcia et al. 1998Go; Ruiz-Velasco and Ikeda 2000Go), with Gbeta5 subunits mediating little or no detectable voltage-dependent inhibition of N-type currents, whereas Gbeta1 results in robust inhibition of these channels (Doering et al. 2004Go).

Efforts to map the inhibitory binding interactions of the N-type and P/Q-type channels with the G-protein beta subunit have yielded evidence suggesting that three intracellular regions of the pore-forming Cav2 subunits of the channels—the amino terminus, the loop-linking domains I and II, and the carboxy terminal region—all contribute to enable binding of the G-protein beta{gamma} complex (Agler et al. 2005Go; Canti et al. 1999Go; De Waard et al. 1997Go; Page et al. 1997Go; Qin et al. 1997Go; Zamponi et al. 1997Go). Complementary efforts to map regions of the G-protein beta subunit that are involved in N-type and P/Q-type channel modulation have resulted in the identification of several amino acid residues on the Gbeta1 subunit, many of which overlapped with the G{alpha} interaction region (Agler et al. 2003Go, 2005Go; Ford et al. 1998Go; Mirshahi et al. 2002aGo). By using series of chimeras between Gbeta1 and Gbeta5 we recently identified a structurally contiguous region of the Gbeta1 molecule that, when replaced by the corresponding Gbeta5 sequence, resulted in complete loss of inhibitory action against the N-type channel (Doering et al. 2004Go). This structurally contiguous region of Gbeta1 constitutes residues 110–112, 140–168, and 186–204 of the primary Gbeta1 structure. Within these regions, mutations of Gbeta1 residues Tyr111 and Asp153 resulted in loss of voltage-dependant inhibition, suggesting their importance for direct binding interactions with the N-type channel (Doering et al. 2004Go).

Here we further characterize the molecular determinants that underlie the inhibitory action of Gbeta1 on the N-type channel. We describe construction of a series of Gbeta1 mutations within regions 140–168 and 186–204, in which individual residues were replaced with those of Gbeta5, and examination of their effects on N-type calcium channel inhibition by paired-pulse facilitation assays. Of all of the mutants examined, only Ser189 of Gbeta1 emerged as a crucial residue for voltage-dependent inhibition of the N-type channel, suggesting that modulation of N-type channels involves highly localized Gbeta subunit structural determinants.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
cDNAs

cDNAs encoding human Gbeta1 and G{gamma}2, rat Gbeta5 were previously described (Arnot et al. 2000Go; Feng et al. 2001Go). Wild-type (WT) rat calcium channel subunit cDNAs were donated by T. Snutch (University of British Columbia). Constructs encoding GIRK1 and GIRK4 subunits were provided by Dr. Hubert van Tol (Center for Addiction and Mental Health, Toronto, Ontario).

Gbeta1 mutants

Using overlap extension PCR methodologies (Ho et al. 1989Go), the following mutants of human Gbeta1 were constructed: G141M, G144N, C148A, R150S, L152T, V158L, S160A, T164G, M188L, S189C, S191D, D195S, L198T, and A203G. In each case, this constitutes a change to the residue at the corresponding position of the primary structure of the rat Gbeta5 molecule. Mutagenic PCRs were performed using Pfu ultra polymerase (Stratagene), according to the manufacturer’s suggestions. Full-length mutant Gbeta1 cDNAs were digested with Xho I and Kpn I (these restriction sites were included in the 5' ends of the nonmutagenic flanking primers designed to anneal to the 5' and 3' ends of the human Gbeta1 open reading frame), then subcloned into Xho I-, Kpn I–double-digested pMT2-XS expression vector. All inserts were sequenced to confirm the presence of the mutations and to rule out PCR errors.

Tissue culture and transient transfection

Human embryonic kidney tsA-201 cells were grown and transfected with calcium phosphate as previously described in detail (Doering et al. 2004Go). In each experiment involving calcium channels, wild-type or mutant rat Cav2.2 calcium channel {alpha}1 subunits were cotransfected with rat beta1b, rat {alpha}2-{delta}1, human G{gamma}2, and an enhanced green fluorescent protein (EGFP) expression marker, plus one of wild-type or mutant Gbeta subunits. For experiments involving GIRK channels, GIRK1 and GIRK4 subunits were used instead of calcium channel subunits. To prevent overgrowth of cells, culture dishes were placed in a 28°C incubator 3–9 h after the washing step performed to remove DNA precipitate from the cultures.

Voltage-clamp recordings of N-type channel currents

Glass coverslips carrying transfected cells were transferred to a 3-cm culture dish containing recording solution consisting of (in mM) 20 BaCl2, 1 MgCl2, 10 HEPES, 40 tetraethylammonium hydroxide, 10 glucose, and 65 CsCl (pH 7.2 with tetraethylammonium-hydroxide). Whole cell patch-clamp recordings were performed as described previously (Doering et al. 2004Go), using internal pipette solution consisting of (in mM) 108 cesium methane-sulfonate, 4 MgCl2, 9 EGTA, and 9 HEPES (pH 7.2). Currents were evoked by stepping from –100 mV to a test potential of +20 mV. G-protein inhibition was assessed by application of a +150-mV prepulse (PP) for 50 ms. Only cells with current amplitudes >50 pA and <1.2 nA were used for analysis. The degree of prepulse relief of tonic G-protein inhibition was determined as the ratio of peak current amplitudes seen after (I+PP) and before (IPP) the prepulse—referred to hereinafter as the paired-pulse facilitation (PPF) ratio and reflects the ability of a given G-protein subunit to inhibit N-type current activity. The PP paradigms were programmed using the "train" and "user list" functions in pCLAMP (Axon Instruments).

Voltage-clamp recordings of GIRK channel currents

Whole cell recordings were performed using an internal solution of (in mM) 100 potassium gluconate, 40 KCl, 10 HEPES, 5 EGTA, 1 MgCl2, and 5 NaCl (pH 7.4 with KOH). External solution consisted of (in mM) 25 KCl, 10 HEPES, 10 glucose, and 116 NaCl (pH 7.4 with NaOH). Under these conditions, the predicted reversal potential of potassium is about –30 mV. GIRK channel activity was tested by holding the cells at –35 mV, followed by application of a voltage ramp from –120 to +60 mV over 525 ms. Only cells displaying inward rectification were used for analysis, and whole cell GIRK conductance was obtained by a linear fit to the inward current observed between the potentials of –100 and –60 mV during the voltage ramp. Whole cell capacitance ranged from 10 to 186 pF. In this range, there was no significant correlation between capacitance and whole cell conductance (Pearson correlation coefficients for matched arrays of capacitance and conductance from cells expressing GIRK1/4 channels were 0.233, 0.247, and 0.609 for data from cells coexpressing either no heterologous Gbeta, heterologous Gbeta1-S189C, or heterologous WT Gbeta1, respectively). Thus data are plotted in Fig. 2B as whole cell conductance rather than current densities. GIRK channel data presented herein were all recorded from one batch of tsA-201 cells of the same passage and culture, cotransfected simultaneously in separate plates, under identical conditions with the exception of the G-protein–expression vectors used (or omitted) to obtain the desired coexpression pattern in the individual transfections.


Figure 2
View larger version (25K):
[in this window]
[in a new window]
 
FIG. 2. AC: whole cell current recordings from tsA-201 cells expressing GIRK1/4 channels, as described in METHODS. A: typical set of current traces recorded from a cell coexpressing heterologous WT Gbeta1, obtained using steps from a holding potential of –35 mV to test potentials ranging from –120 to +60 mV. B: typical set of current traces, obtained as in A, but from a cell coexpressing Gbeta1-S189C. C: typical voltage-ramp traces, plotted as current–voltage relations, obtained from experiments performed with cells coexpressing either no heterologous Gbeta, or Gbeta1-S189C, or WT Gbeta1 (as indicated by labels at the bottom left ends of the traces). D: histogram summarizing analysis of results obtained for the 3 experimental conditions described in C; for all 3 conditions, conductances were calculated for voltage-ramp recording data collected between transmembrane potentials of –100 and –60 mV; columns are shown with SE bars, with corresponding experimental condition indicated by labels below the respective columns; asterisks indicate statistically significant difference from conductances calculated from negative control cells (labeled "–Gbeta1"). Numbers in parentheses indicate numbers of cells tested.

 
Voltage-clamp data analysis

All electrophysiological data were analyzed using Clampfit (Axon Instruments) and fitted in Sigmaplot 2000 (SPSS) or Microsoft Excel. Statistical analysis was carried out in SigmaStat 2.03 (SPSS). A Kruskal–Wallis one-way ANOVA on ranks (Dunn’s method) was performed on N-type calcium channel data; assuming normal distribution (based on passed normality test) a one-way ANOVA was performed using a post hoc Tukey test on GIRK channel data.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
We previously showed that substitution of residues 140–168 or residues 186–204 of Gbeta1 with the corresponding residues of Gbeta5 yields a chimera that cannot induce voltage-dependent inhibition of the N-type channel (Doering et al. 2004Go). Alignment of the human Gbeta1 sequences for residues 140–168 and 186–204 with the corresponding rat Gbeta5 sequences revealed 14 nonconserved residues. To identify which of these individual amino acid residues were critical for G-protein modulation of the N-type channel, responsible for this effect, we systematically replaced Gbeta1 residues with those corresponding to the Gbeta5 sequence. The resulting mutant Gbeta1 constructs were coexpressed in HEK (human embryonic kidney) cells with N-type channel subunits and an EGFP expression marker. Voltage-dependent G-protein inhibition of N-type currents was assessed by using a PPF paradigm (see METHODS), wherein alternating test potentials were recorded after application of +150-mV depolarizing prepulses intended to disrupt inhibitory interaction of Gbeta subunits and N-type channels (Fig. 1). As controls and to establish a baseline, N-type channels were also coexpressed either with heterologous WT Gbeta1 or without any heterologous Gbeta, and PPF was tested under both conditions. As illustrated by current traces shown in Fig. 1A, application of prepulses to cells coexpressing heterologous WT Gbeta1 resulted in substantially larger and more rapidly activating N-type currents (Fig. 1A, right traces), but prepulses applied to cells not expressing heterologous Gbeta typically resulted in only negligible changes (Fig. 1A, left traces), as expected from the absence of G-protein modulation.


Figure 1
View larger version (33K):
[in this window]
[in a new window]
 
FIG. 1. A: 3 sets of typical current traces from tsA-201 cells expressing the rat N-type calcium channel, as described in METHODS. Each is a matched set of current traces from sequential test pulses, with the second test pulse preceded by a +150-mV depolarizing prepulse. (In each set the trace with larger current values is from the second test pulse.) Left: traces from a cell expressing no heterologous Gbeta. Center: traces from a cell coexpressing the Gbeta1-S189C mutant. Right: traces from a cell coexpressing WT Gbeta1. B: histogram summarizing the results of paired-pulse facilitation (PPF) experiments performed with all Gbeta1 mutants; columns shown with SE bars. Respective positions of mutations in the Gbeta1 amino acid sequence are indicated by numbers beneath the corresponding columns (see METHODS for full description of the mutations used). Stars above the S189C ("189") and negative control columns ("Ctrl") indicate that these 2 data sets scored P < 0.05 in an ANOVA on ranks test against positive control data ("WT"). Numbers in parentheses indicate numbers of cells tested.

 
The results of PPF assays performed with the 14 Gbeta1 mutants are summarized in Fig. 1B. Among the 14 mutants, 11 yielded PPF ratios that were similar to those obtained with WT channels. Two additional mutants, G144N and M188L, appeared to result in a somewhat reduced degree of prepulse facilitation; however, although a Student’s t-test indicated significant differences for these two residues (P values of 0.003 and 0.004, respectively), the respective distributions of PPF values failed the normality test and analysis by ANOVA on ranks indicated that this reduction did not reach statistical significance in either case. In contrast, the S189C mutant yielded an average PPF ratio slightly lower than that of negative control assays (1.13 and 1.16, respectively), which was significantly different from that observed with WT Gbeta1 (difference of ranks score, 141.9; P < 0.05).

To eliminate the possibility that the S189C mutant might not express, or not fold correctly, we examined the abilities of both Gbeta1-S189C and WT Gbeta1 to activate GIRK1/4 channels expressed in tsA-201 cells. As illustrated by raw current trace ensembles in Fig. 2, A and B, large inward K+ currents were observed at negative test potentials in cells coexpressing GIRK1/4 channels and either Gbeta1-S189C or heterologous WT Gbeta1, with significant rectification at more positive test potentials. Inward K+ currents recorded as negative controls from cells with no heterologous Gbeta were substantially smaller (see Fig. 2C). ANOVA analysis of whole cell conductances (calculated for ramp potentials between –100 and –60 mV) confirmed a statistically significant difference between K+ conductances of cells with no heterologous Gbeta compared with cells expressing either Gbeta1-S189C or WT Gbeta1 (Fig. 2D), but with no statistically significant difference between the latter two conditions. These results thus confirm the expected functionality of the Gbeta1-S189C mutant in the activation of GIRK1/4 channels, consistent with the view that Ser189 is required for direct modulatory interactions with the N-type calcium channel, but not for proper Gbeta folding and expression.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Although the bioactive surfaces of peptide toxins and hormones are often studied using comprehensive scanning mutagenesis of all solvent-exposed amino acid residues (Froy et al. 1999Go; Kristensen et al. 1997Go; Maggio and King 2002Go; Nadasdi et al. 1995Go; Tedford et al. 2001Go, 2004Go), the Gbeta subunit is 10- to 50-fold larger than the typical subjects of these studies—a poor prospect for comprehensive scanning mutagenesis, in view of the resources that would be required. Structure–activity relationship (SAR) studies of the Gbeta subunit have thus avoided comprehensive scanning approaches, instead imposing limits on the structural variants tested by using chimeras of Gbeta subtypes (Mirshahi et al. 2002bGo), or in other cases using targeted mutations of structural regions suspected to be significant based on interactions observed in cocrystal structures (Agler et al. 2003Go).

Here, we used a scanning mutagenesis approach, but limited it to examination of 14 Gbeta1 residues in sequence regions 140–168 and 186–204, areas previously identified in our tests of a panel of chimeras of Gbeta1 and Gbeta5 (Doering et al. 2004Go). Our data show that only one of these 14 residues (Ser189) significantly contributed to voltage-dependent channel modulation. Taken together with our previous results, there appear to be three residues of Gbeta1—Tyr111, Asp153, and Ser189—that are required for voltage-dependent inhibition of N-type channels (Doering et al. 2004Go). Consistent with their critical role in modulating N-type channels, these residues are all highly conserved in Gbeta1 orthologs expressed in human, rat, and mouse. Moreover, sequence alignment indicates that they are also conserved in any of the known human Gbeta subtypes (i.e., Gbeta1–4) that are capable of modulating the N-type channel (Arnot et al. 2000Go). As illustrated in Fig. 3, the three residues are noncontiguous in the three-dimensional structure of Gbeta1—a situation with many precedents because SAR studies of conotoxins, spider toxins, and also Gbeta{gamma} modulation of effectors other than N-type calcium channels have all identified noncontiguous residues presumed to participate directly in functional contacts with their respective targets (Agler et al. 2003Go; Lew et al. 1997Go; Maggio and King 2002Go; Mirshahi et al. 2002bGo). The side chains of Tyr111 and Asp153 each protrude outward from the rest of the structure and would presumably be quickly accessible for interactions with intracellular loops of the {alpha}1B subunit of the N-type channel. By contrast, Ser189 is situated in a concavity in the center of the structure, with only the {gamma}-OH functionality at the distal end of its side chain exposed to the aqueous solution at the structural surface. Thus the kinetics of its binding interactions with the N-type channel would be slow relative to Tyr111 and Asp153, although this would have to be confirmed by biochemical means. However, precedents exist in the literature both for binding epitopes that protrude from protein structures and also for less-accessible binding epitopes situated in concavities of protein surfaces (Bogan and Thorn 1998Go; Kim et al. 1995Go; Tedford et al. 2004Go). We should also note that Ser189 does not appear to form a serine kinase consensus site (as evaluated by PROSITE analysis), and thus the loss of N-type channel inhibition is not attributable to altered phosphorylation of Gbeta1.


Figure 3
View larger version (34K):
[in this window]
[in a new window]
 
FIG. 3. A: molecular surface rendering of WT Gbeta1, calculated using crystal structure data reported by Sondek et al. (1996). Shown in green are surface areas presented by residues 110–112, 140–168, and 186–204, previously identified as key determinants of N-type channel modulation (Doering et al. 2004). Areas presented by the side chains of Tyr111, Asp153, and Ser189 are shown in orange-red. B: ribbon cartoon model representing the WT Gbeta1 structure. Areas corresponding to residues 110–112, 140–168, and 186–204 are shown in green; side chains of Tyr111, Asp153, and Ser189 are represented in orange-red. Molecular images were drawn using MOLMOL (Koradi et al. 1996).

 
Our previous findings with rat Gbeta5 indicate that this subunit is unable to modulate N-type channel activity (Arnot et al. 2000Go). Interestingly, human Gbeta5{gamma}2 has been shown to inhibit heterologously expressed human N-type calcium channels (Zhou et al. 2000Go), and mouse Gbeta5{gamma}2 can inhibit native N-type currents in rat superior cervical ganglion neurons (Garcia et al. 1998Go; Ruiz-Velasco and Ikeda 2000Go). Considering the propensity of certain Gbeta5 subunits to regulate N-type channels, why then would replacement of a Gbeta1 residue with corresponding Gbeta5 residue result in a loss of N-type channel regulation, in particular when this Gbeta5 residue is conserved in rat, mouse, and human? One possible explanation may lie in the Gbeta5 subunit isoforms used in the latter two studies. The N-terminus region of mouse (GenBank accession number P62881) Gbeta5 contains about 40 additional amino acid residues compared with the rat Gbeta5 subunit used in our previous work (GenBank accession number AAS59141), and this extended N-terminus is not seen with Gbeta1. Considering that the remainder of the mouse Gbeta5 sequences are >99% identical to the rat isoform, this implies an important role of the extended N-terminus in N-type channel modulation. Because the Gbeta1 and Gbeta5 subunits used in our experiments do not contain extended N-termini and our Gbeta5 subunit is incapable of inhibiting N-type channel activity, the loss of Gbeta1 subunit regulation of the channel that occurs on substitution of certain key residues with Gbeta5 sequence is thus expected. The human Gbeta5 subunit used by Zhou and coworkers (2000)Go is virtually identical to shorter rat isoform used in our study, although the former study involved human rather than rat Cav2.2 channels, thus making firm comparisons difficult.

Substitution of two additional residues, Gly144 and Met188 (which are conserved in Gbeta1 through Gbeta4), was found to reduce the degree of prepulse relief, although the statistical significance of this effect depended on the statistical analysis used (i.e., ANOVA vs. t-test). These two residues are situated on the opposite face of the Gbeta subunit compared with Tyr111, Asp153, and Ser189 (not shown), and thus they are unlikely to mediate their effects by altering channel interactions with these three residues. However, they are located in close proximity to other Gbeta1 residues (i.e., Thr142, Asp119, Met101) previously implicated in N-type channel modulation by Ford and colleagues (1998)Go, thus perhaps accounting for a possible partial effect. It is unlikely that the substitution of these two residues would result in gross alterations in the overall Gbeta structure because substitution of larger regions of Gbeta1 flanking these residues with Gbeta5 sequence preserves the ability of such chimeric constructs to activate GIRK channels (Doering et al. 2004Go).

Particularly remarkable is the presence of several unique ensembles of modulatory epitopes in the structure of Gbeta, all of which contribute to Gbeta modulation of a different effector molecule—e.g., N-type and P/Q-type calcium channels, GIRK channels, adenylyl cyclase, and phospholipase beta2 (Agler et al. 2003Go; Ford et al. 1998Go; Mirshahi et al. 2002aGo). All of these effector interaction sites are localized to the G{alpha} interaction domain of Gbeta1 (Agler et al. 2003Go; Ford et al. 1998Go; Mirshahi et al. 2002aGo). However, the N-type channel may be unique among these effectors because the critical modulatory residues identified by our present study are situated on the Gbeta surface opposite to that involved in G{alpha} binding (see Fig. 3). The presence of multiple, widely dispersed N-type channel interaction sites on the Gbeta subunit is consistent with the notion that several Gbeta binding regions (i.e., N-terminus, I–II linker region) have been identified on the channel (Agler et al. 2005Go; Zamponi et al. 1997Go). The alignment of the three critical residues highlighted in Fig. 3 in a ribbonlike fashion may be indicative of specific contact points with a single one of these channel regions. Ultimately, mutation complementation experiments may be needed to identify which channel residues participate in such mutual interactions. Nonetheless, our data point to highly specific sequence differences between Gbeta5 and the four other known Gbeta subunit subtypes that underlie the Gbeta subtype specificity of N-type channel modulation.


    GRANTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
This work was supported by an operating grant to G. W. Zamponi from the Canadian Institutes of Health Research. G. W. Zamponi is a Canada Research Chair and a senior scholar of the Alberta Heritage Foundation for Medical Research (AHFMR). H. W. Tedford holds postdoctoral fellowships from the AHFMR and the Heart and Stroke Foundation of Canada (HSF-Canada). A. E. Kisilevsky holds studentships from AHFMR and HSF-Canada and J. B. Peloquin is the recipient of a studentship from the Canadian Foundation for Fighting Blindness.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
We thank C. Doering, C. Bladen, J. McRory, and J. Hamid for assistance with DNA constructs and technical issues of molecular biology and electrophysiology. We also thank L. Chen and W. Barr for assistance with cell culture.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Address for reprint requests and other correspondence: G. W. Zamponi, Department of Physiology and Biophysics, University of Calgary, 3330 Hospital Dr. NW, Calgary, T2N 4N1, Canada (E-mail. zamponi{at}ucalgary.ca)


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Agler HL, Evans J, Colecraft HM, and Yue DT. Custom distinctions in the interaction of G-protein beta subunits with N-type (CaV2.2) versus P/Q-type (CaV2.1) calcium channels. J Gen Physiol 121: 495–510, 2003.[Abstract/Free Full Text]

Agler HL, Evans J, Tay LH, Anderson MJ, Colecraft HM, and Yue DT. G protein-gated inhibitory module of N-type (Ca(v)2.2) Ca2+ channels. Neuron 46: 891–904, 2005.[CrossRef][ISI][Medline]

Arnot MI, Stotz SC, Jarvis SE, and Zamponi GW. Differential modulation of N-type 1B and P/Q-type 1A calcium channels by different G protein subunit isoforms. J Physiol 527: 203–212, 2000.[Abstract/Free Full Text]

Bogan AA and Thorn KS. Anatomy of hot spots in protein interfaces. J Mol Biol 280: 1–9, 1998.[CrossRef][ISI][Medline]

Canti C, Page KM, Stephens GJ, and Dolphin AC. Identification of residues in the N terminus of alpha1B critical for inhibition of the voltage-dependent calcium channel by Gbeta gamma. J Neurosci 19: 6855–6864, 1999.[Abstract/Free Full Text]

De Waard M, Liu H, Walker D, Scott VE, Gurnett CA, and Campbell KP. Direct binding of G-protein beta-gamma complex to voltage-dependent calcium channels. Nature 385: 446–450, 1997.[CrossRef][Medline]

Doering CJ, Kisilevsky AE, Feng ZP, Arnot MI, Peloquin J, Hamid J, Barr W, Nirdosh A, Simms B, Winkfein RJ, and Zamponi GW. A single Gbeta subunit locus controls cross-talk between protein kinase C and G protein regulation of N-type calcium channels. J Biol Chem 279: 29709–29717, 2004.[Abstract/Free Full Text]

Dolphin AC. G protein modulation of voltage-gated calcium channels. Pharmacol Rev 55: 607–627, 2003.[Abstract/Free Full Text]

Dunlap K, Luebke JI, and Turner TJ. Exocytotic Ca2+ channels in mammalian central neurons. Trends Neurosci 18: 89–98, 1995.[CrossRef][ISI][Medline]

Feng ZP, Arnot MI, Doering CJ, and Zamponi GW. Calcium channel beta subunits differentially regulate the inhibition of N-type channels by individual Gbeta isoforms. J Biol Chem 276: 45051–45058, 2001.[Abstract/Free Full Text]

Ford CE, Skiba NP, Bae H, Daaka Y, Reuveny E, Shekter LR, Rosal R, Weng G, Yang CS, Iyengar R, Miller RJ, Jan LY, Lefkowitz RJ, and Hamm HE. Molecular basis for interactions of G protein betagamma subunits with effectors. Science 280: 1271–1274, 1998.[Abstract/Free Full Text]

Froy O, Zilberberg N, Gordon D, Turkov M, Gilles N, Stankiewicz M, Pelhate M, Loret E, Oren DA, Shaanan B, and Gurevitz M. The putative bioactive surface of insect-selective scorpion excitatory neurotoxins. J Biol Chem 274: 5769–5776, 1999.[Abstract/Free Full Text]

Garcia DE, Li B, Garcia-Ferreiro RE, Hernandez-Ochoa EO, Yan K, Gautam N, Catterall WA, Mackie K, and Hille B. G-protein beta-subunit specificity in the fast membrane-delimited inhibition of Ca2+ channels. J Neurosci 18: 9163–9170, 1998.[Abstract/Free Full Text]

Ho SN, Hunt HD, Horton RM, Pullen JK, and Pease LR. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51–59, 1989.[CrossRef][ISI][Medline]

Kim JI, Takahashi M, Ohtake A, Wakamiya A, and Sato K. Tyr13 is essential for the activity of {omega}-conotoxin MVIIA and GVIA, specific N-type calcium channel blockers. Biochem Biophys Res Commun 206: 449–454, 1995.[CrossRef][ISI][Medline]

Koradi R, Billeter M, and Wüthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 14: 51–55, 1996.[CrossRef][ISI][Medline]

Kristensen C, Kjeldsen T, Wiberg FC, Schaffer L, Hach M, Havelund S, Bass J, Steiner DF, and Andersen AS. Alanine scanning mutagenesis of insulin. J Biol Chem 272: 12978–12983, 1997.[Abstract/Free Full Text]

Lew MJ, Flinn JP, Pallaghy PK, Murphy R, Whorlow SL, Wright CE, Norton RS, and Angus JA. Structure-function relationships of {omega}-conotoxin GVIA: synthesis, structure, calcium channel binding, and functional assay of alanine-substituted analogues. J Biol Chem 272: 12014–12023, 1997.[Abstract/Free Full Text]

Maggio F and King GF. Scanning mutagenesis of a Janus-faced atracotoxin reveals a bipartite surface patch that is essential for neurotoxic function. J Biol Chem 277: 22806–22813, 2002.[Abstract/Free Full Text]

Mirshahi T, Mittal V, Zhang H, Linder ME, and Logothetis DE. Distinct sites on G protein beta gamma subunits regulate different effector functions. J Biol Chem 277: 36345–36350, 2002a.[Abstract/Free Full Text]

Mirshahi T, Robillard L, Zhang H, Hebert TE, and Logothetis DE. Gbeta residues that do not interact with Galpha underlie agonist-independent activity of K+ channels. J Biol Chem 277: 7348–7355, 2002b.[Abstract/Free Full Text]

Nadasdi L, Yamashiro D, Chung D, Tarczy-Hornoch K, Adriaenssens P, and Ramachandran J. Structure-activity analysis of a Conus peptide blocker of N-type neuronal calcium channels. Biochemistry 34: 8076–8081, 1995.[CrossRef][Medline]

Page KM, Stephens GJ, Berrow NS, and Dolphin AC. The intracellular loop between domains I and II of the B-type calcium channel confers aspects of G-protein sensitivity to the E-type calcium channel. J Neurosci 17: 1330–1338, 1997.[Abstract/Free Full Text]

Qin N, Platano D, Olcese R, Stefani E, and Birnbaumer L. Direct interaction of gbeta-gamma with a C-terminal gbeta-gamma-binding domain of the Ca2+ channel alpha1 subunit is responsible for channel inhibition by G protein-coupled receptors. Proc Natl Acad Sci USA 94: 8866–8871, 1997.[Abstract/Free Full Text]

Ruiz-Velasco V and Ikeda SR. Multiple G-protein betagamma combinations produce voltage-dependent inhibition of N-type calcium channels in rat superior cervical ganglion neurons. J Neurosci 20: 2183–2191, 2000.[Abstract/Free Full Text]

Sondek J, Bohm A, Lambright DG, Hamm HE, and Sigler PB. Crystal structure of a G-protein beta gamma dimer at 2.1A resolution. Nature 379: 369–374, 1996.[CrossRef][Medline]

Tedford HW, Fletcher JI, and King GF. Functional significance of the beta-hairpin in the insecticidal neurotoxin {omega}-atracotoxin-Hv1a. J Biol Chem 276: 26568–26576, 2001.[Abstract/Free Full Text]

Tedford HW, Gilles N, Menez A, Doering CJ, Zamponi GW, and King GF. Scanning mutagenesis of omega-atracotoxin-Hv1a reveals a spatially restricted epitope that confers selective activity against insect calcium channels. J Biol Chem 279: 44133–44140, 2004.[Abstract/Free Full Text]

Wheeler DB, Randall A, and Tsien RW. Roles of N-type and Q-type Ca2+ channels in supporting hippocampal synaptic transmission. Science 264: 107–111, 1994.[Abstract/Free Full Text]

Zamponi GW. Determinants of G protein inhibition of presynaptic calcium channels. Cell Biochem Biophys 34: 79–94, 2001.[CrossRef][ISI][Medline]

Zamponi GW, Bourinet E, Nelson D, Nargeot J, and Snutch TP. Crosstalk between G proteins and protein kinase C mediated by the calcium channel alpha1 subunit. Nature 385: 442–446, 1997.[CrossRef][Medline]

Zhou JY, Siderovski DP, and Miller RJ. Selective regulation of N-type Ca channels by different combinations of G-protein beta/gamma subunits and RGS proteins. J Neurosci 20: 7143–7148, 2000.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. D. DePuy, J. Yao, C. Hu, W. McIntire, I. Bidaud, P. Lory, F. Rastinejad, C. Gonzalez, J. C. Garrison, and P. Q. Barrett
The molecular basis for T-type Ca2+ channel inhibition by G protein beta2{gamma}2 subunits
PNAS, September 26, 2006; 103(39): 14590 - 14595.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
96/1/465    most recent
00216.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tedford, H. W.
Right arrow Articles by Zamponi, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tedford, H. W.
Right arrow Articles by Zamponi, G. W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the The American Physiological Society.